| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
makorin ring finger protein 3 | 0.619 | 0.615 | 0.28 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
thyroid stimulating hormone receptor | 0.486 | 0.808 | 3.0E-15 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
mitogen-activated protein kinase kinase kinase 7 | 0.477 | 0.808 | 1.00 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 | 0.527 | 0.769 | 1.00 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
nuclear receptor binding SET domain protein 1 | 0.505 | 0.769 | 1.00 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
potassium inwardly rectifying channel subfamily J member 8 | 0.619 | 0.538 | 0.38 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
archain 1 | 0.705 | 0.462 | 1.00 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
insulin receptor | 0.432 | 0.846 | 3.6E-05 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
glypican 4 | 0.547 | 0.769 | 0.93 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
enhancer of zeste 2 polycomb repressive complex 2 subunit | 0.376 | 0.885 | 1.00 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
aggrecan | 0.528 | 0.846 | 1.00 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit | 0.644 | 0.692 | 6.1E-04 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
cytochrome P450 family 19 subfamily A member 1 | 0.410 | 0.885 | 1.7E-05 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
cytochrome P450 family 11 subfamily B member 1 | 0.563 | 0.615 | 8.2E-07 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
calcium activated nucleotidase 1 | 0.619 | 0.731 | 2.5E-06 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
beta-1,4-galactosyltransferase 7 | 0.628 | 0.654 | 1.1E-04 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
KCNQ1 opposite strand/antisense transcript 1 | 0.534 | 0.731 |
|
phenotype | 0.100 | None | 0 | 0 | ||||||||||||
|
1-acylglycerol-3-phosphate O-acyltransferase 2 | 0.585 | 0.654 | 1.2E-07 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
H19/IGF2 imprinting control region | 0.631 | 0.615 |
|
phenotype | 0.100 | None | 0 | 0 | ||||||||||||
|
APC regulator of WNT signaling pathway 2 | 0.582 | 0.654 | 1.00 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
cyclin dependent kinase inhibitor 1C | 0.456 | 0.846 | 0.82 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
filamin A | 0.419 | 0.846 | 1.00 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
solute carrier family 35 member D1 | 0.736 | 0.385 | 3.6E-04 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
inositol polyphosphate phosphatase like 1 | 0.590 | 0.769 | 2.3E-03 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
insulin like growth factor 2 | 0.390 | 0.885 | 4.4E-02 |
|
phenotype | 0.100 | None | 0 | 0 |